#doc_wsj_0032.tml_sent_0
0	Italian	O	_	['N']	[0]
1	chemical	O	_	['N']	[1]
2	giant	O	_	['N']	[2]
3	Montedison	O	_	['N']	[3]
4	S.p.A.	O	_	['N']	[4]
5	,	O	_	['N']	[5]
6	through	O	_	['N']	[6]
7	its	O	_	['N']	[7]
8	Montedison	O	_	['N']	[8]
9	Acquisition	O	_	['N']	[9]
10	N.V.	O	_	['N']	[10]
11	indirect	O	_	['N']	[11]
12	unit	O	_	['N']	[12]
13	,	O	_	['N']	[13]
14	began	B-EVENT	ASPECTUAL	['BEGINS', 'INITIATES']	[21, 21]
15	its	O	_	['N']	[15]
16	$	O	_	['N']	[16]
17	37	O	_	['N']	[17]
18	-	O	_	['N']	[18]
19	a-share	O	_	['N']	[19]
20	tender	O	_	['N']	[20]
21	offer	B-EVENT	OCCURRENCE	['N']	[21]
22	for	O	_	['N']	[22]
23	all	O	_	['N']	[23]
24	the	O	_	['N']	[24]
25	common	O	_	['N']	[25]
26	shares	O	_	['N']	[26]
27	outstanding	O	_	['N']	[27]
28	of	O	_	['N']	[28]
29	Erbamont	O	_	['N']	[29]
30	N.V.	O	_	['N']	[30]
31	,	O	_	['N']	[31]
32	a	O	_	['N']	[32]
33	maker	O	_	['N']	[33]
34	of	O	_	['N']	[34]
35	pharmaceuticals	O	_	['N']	[35]
36	incorporated	O	_	['N']	[36]
37	in	O	_	['N']	[37]
38	the	O	_	['N']	[38]
39	Netherlands	O	_	['N']	[39]
40	.	O	_	['N']	[40]
#doc_wsj_0032.tml_sent_1
41	The	O	_	['N']	[41]
42	offer	B-EVENT	OCCURRENCE	['IDENTITY', 'BEFORE', 'BEFORE']	[21, 44, 58]
43	,	O	_	['N']	[43]
44	advertised	B-EVENT	OCCURRENCE	['IS_INCLUDED', 'EVIDENTIAL']	[46, 42]
45	in	O	_	['N']	[45]
46	today	B-TIMEX3	DATE	['IDENTITY']	[-1]
47	's	O	_	['N']	[47]
48	editions	O	_	['N']	[48]
49	of	O	_	['N']	[49]
50	The	O	_	['N']	[50]
51	Wall	O	_	['N']	[51]
52	Street	O	_	['N']	[52]
53	Journal	O	_	['N']	[53]
54	,	O	_	['N']	[54]
55	is	O	_	['N']	[55]
56	scheduled	B-EVENT	I_ACTION	['IS_INCLUDED', 'MODAL']	[-1, 58]
57	to	O	_	['N']	[57]
58	expire	B-EVENT	OCCURRENCE	['ENDED_BY']	[61]
59	at	O	_	['N']	[59]
60	the	O	_	['N']	[60]
61	the	B-TIMEX3	_	['N']	[61]
62	end	I-TIMEX3	_	['N']	[62]
63	of	I-TIMEX3	_	['N']	[63]
64	November	I-TIMEX3	TIME	['N']	[64]
65	.	O	_	['N']	[65]
#doc_wsj_0032.tml_sent_2
66	Montedison	O	_	['N']	[66]
67	currently	B-TIMEX3	DATE	['INCLUDES', 'INCLUDES']	[-1, 68]
68	owns	B-EVENT	STATE	['N']	[68]
69	about	O	_	['N']	[69]
70	72	O	_	['N']	[70]
71	%	O	_	['N']	[71]
72	of	O	_	['N']	[72]
73	Erbamont	O	_	['N']	[73]
74	's	O	_	['N']	[74]
75	common	O	_	['N']	[75]
76	shares	O	_	['N']	[76]
77	outstanding	O	_	['N']	[77]
78	.	O	_	['N']	[78]
#doc_wsj_0032.tml_sent_3
79	The	O	_	['N']	[79]
80	offer	B-EVENT	OCCURRENCE	['IDENTITY', 'BEGUN_BY']	[42, 83]
81	is	O	_	['N']	[81]
82	being	O	_	['N']	[82]
83	launched	B-EVENT	I_ACTION	['IS_INCLUDED', 'AFTER', 'FACTIVE']	[-1, 89, 80]
84	pursuant	O	_	['N']	[84]
85	to	O	_	['N']	[85]
86	a	O	_	['N']	[86]
87	previously	B-TIMEX3	TIME	['BEFORE']	[-1]
88	announced	B-EVENT	REPORTING	['SIMULTANEOUS', 'EVIDENTIAL']	[87, 89]
89	agreement	B-EVENT	OCCURRENCE	['BEFORE']	[88]
90	between	O	_	['N']	[90]
91	the	O	_	['N']	[91]
92	companies	O	_	['N']	[92]
93	.	O	_	['N']	[93]